Literature DB >> 31625388

Chrysin Effect in Prevention of Acetaminophen-Induced Hepatotoxicity in Rat.

Arezoo Mohammadi1, Sohrab Kazemi2, Mohammad Hosseini3, Hoseyn Najafzadeh Varzi2, Farideh Feyzi2, Payam Morakabati1, Ali Akbar Moghadamnia2,4.   

Abstract

Acetaminophen is a commonly used analgesic drug that induces hepatotoxicity at high doses and produces the acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) through oxidase isoenzyme system. The antioxidant and anti-inflammatory activity of flavonoid chrysin has been reported in different studies. The present study was conducted to investigate the protective effect of chrysin on acute acetaminophen-induced hepatotoxicity. The cytotoxicity of chrysin on fibroblast cells was evaluated using MTT assay, and then, 54 rats were divided into nine groups of six, and acetaminophen (1500 mg/kg) was administered in all groups except for the control group, second and the seventh groups (40 mg/kg), and all groups were treated with chrysin for 14 days. Liver enzymes, inflammatory factors TNF-α and IL-2, and total antioxidant activity were measured in serum while liver tissue was histopathologically examined. Based on the MTT assay results, 31.25, 62.5, 125, 250, and 500 μg/mL chrysin had no adverse effects on healthy fibroblast cells (P < 0.05). Chrysin decreased the level of liver enzymes (ALT, AST, and ALP), which were previously increased after the use of acetaminophen (p < 0.05). The hepatoprotective effect and total antioxidant capacity increased in a dose-dependent manner and the effect of the highest concentration of chrysin was equal to the effect of silymarin (P < 0.05). TNF-α in groups 4 to 6 decreased in a dose-dependent manner (P = 0.04), and chrysin did not show any significant reducing effect on IL-2 compared to silymarin. Chrysin prevents the necrosis and injury of acute acetaminophen-induced hepatotoxicity by decreasing liver enzymes and TNF-α and increasing total antioxidant capacity and protecting the liver tissue.

Entities:  

Year:  2019        PMID: 31625388     DOI: 10.1021/acs.chemrestox.9b00332

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Chrysin Attenuates Fructose-Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti-Inflammatory Effects: The Role of Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis.

Authors:  Hala Attia; Norah Albekairi; Layal Albdeirat; Arwa Soliman; Reem Rajab; Hend Alotaibi; Rehab Ali; Amira Badr
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

Review 2.  Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.

Authors:  Monika Stompor-Gorący; Agata Bajek-Bil; Maciej Machaczka
Journal:  Nutrients       Date:  2021-06-14       Impact factor: 5.717

3.  Galangin Nanoparticles Protect Acetaminophen-Induced Liver Injury: A Biochemical and Histopathological Approach.

Authors:  Arezoo Mohammadi; Sohrab Kazemi; Inas Molayousefian; Marzieh Pirzadeh; Ali Akbar Moghadamnia
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

Review 4.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.